Answers are grounded in this paper and cite their sources.
A patient is described with 18p- syndrome and hypopituitarism. This is the first patient with this syndrome who has been shown to benefit from growth hormone therapy. Patients with this syndrome who have growth deficiency should be considered for evaluation for hypopituitarism, if the quality of their lives would improve with an increase in stature.
No takes yet. Share an insight, caveat, or question.
Artman et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: